PEPTIDE-INDUCED GROOMING BEHAVIOR AND CAUDATE-NUCLEUS DOPAMINE RELEASE

被引:26
作者
FLORIJN, WJ [1 ]
HOLTMAAT, AJGD [1 ]
DELANG, H [1 ]
SPIERENBURG, H [1 ]
GISPEN, WH [1 ]
VERSTEEG, DHG [1 ]
机构
[1] UNIV UTRECHT,FAC MED,RUDOLF MAGNUS INST,DEPT PHARMACOL,VONDELLAAN 6,3521 GD UTRECHT,NETHERLANDS
关键词
GROOMING BEHAVIOR; DOPAMINE RELEASE IN-VIVO; MICRODIALYSIS; ACTH-(1-24);
D O I
10.1016/0006-8993(93)90151-C
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We simultaneously measured the display of grooming behavior and, by monitoring the extracellular dopamine concentration via transversal microdialysis, the release of dopamine in the caudate nucleus in freely moving rats after i.c.v. administration of 1 mug adrenocorticotropic hormone-(1-24) (ACTH-(1-24)). During a period of 1 h after administration of the peptide, the incidence of excessive grooming behavior was increased. Concomitantly, the concentration of dopamine in the caudate nucleus dialysates was significantly increased (maximal effect 151% of basal release) whereas that of its metabolite DOPAC was unchanged. The potent alpha-melanocyte stimulating hormone (alpha-MSH) receptor agonist, [Nle4 D-Phe 7]alpha-MSH, induced grooming behavior and stimulated caudate nucleus dopamine release (maximal effect 148% of basal release) whereas ACTH-(7-16)-NH2 did neither induce grooming behavior nor cause an increase in caudate nucleus dopamine release. Single-dose tolerance was observed for ACTH-induced grooming but not for ACTH-induced dopamine release. These data are in support of the proposed involvement of brain dopamine systems in grooming behavior of the rat but at the same time suggest that the effect of ACTH/MSH-like peptides on dopaminergic transmission in the caudate nucleus is proximal to the final neural pathway involved in ACTH-induced grooming behavior.
引用
收藏
页码:169 / 172
页数:4
相关论文
共 17 条
[1]  
BRAKKEE JH, 1979, LAB ANIM SCI, V29, P78
[2]  
EBERLE AN, 1988, MALANOCORTINS CHEM P
[3]   ACTH MSH-LIKE PEPTIDES INHIBIT THE BINDING OF DOPAMINERGIC LIGANDS TO THE DOPAMINE D2 RECEPTOR INVITRO [J].
FLORIJN, WJ ;
DEBOER, T ;
TONNAER, JADM ;
VANNISPEN, JW ;
VERSTEEG, DHG .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 207 (01) :43-50
[4]  
FLORIJN WJ, 1992, J PHARMACOL EXP THER, V263, P797
[5]   D-1 DOPAMINE-RECEPTORS LABELED WITH H-3 SCH-23390 - DECREASE IN THE STRIATUM OF AGED RATS [J].
GIORGI, O ;
CALDERINI, G ;
TOFFANO, G ;
BIGGIO, G .
NEUROBIOLOGY OF AGING, 1987, 8 (01) :51-54
[6]   INDUCTION OF EXCESSIVE GROOMING IN RAT BY INTRAVENTRICULAR APPLICATION OF PEPTIDES DERIVED FROM ACTH - STRUCTURE-ACTIVITY STUDIES [J].
GISPEN, WH ;
WIEGANT, VM ;
GREVEN, HM ;
WIED, DD .
LIFE SCIENCES, 1975, 17 (04) :645-652
[7]  
GISPEN WH, 1986, NEUROPEPTIDES BEHAVI, V1, P273
[8]  
IMPERATO A, 1984, J NEUROSCI, V4, P966
[9]   REDUCED BEHAVIORAL EFFECTIVENESS OF ACTH-1-24 AFTER A 2ND ADMINISTRATION - INTERACTION WITH OPIATES [J].
JOLLES, J ;
WIEGANT, VM ;
GISPEN, WH .
NEUROSCIENCE LETTERS, 1978, 9 (2-3) :261-266
[10]   EFFECT OF THE DOPAMINE-D2 RECEPTOR AGONIST QUINPIROLE ON THE INVIVO RELEASE OF DOPAMINE IN THE CAUDATE-NUCLEUS OF HYPERTENSIVE RATS [J].
LINTHORST, ACE ;
DELANG, H ;
DEJONG, W ;
VERSTEEG, DHG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 201 (2-3) :125-133